HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.
Print Friendly, PDF & Email

NCT/Study#

NA /

MOLECULAR-PROFILING-SAMPLING

Molecular profiling in patients with advanced lung or thymic cancer previously treated with immune checkpoint inhibitor therapy.

DISEASE GROUP:
Phase 1 (Thoracic)
current phase:
NA
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: